Sorry, you need to enable JavaScript to visit this website.

Learning About XARELTO® | XARELTO® (rivaroxaban) Welcome Kit

Prescription Icon A potentially life-threatening complication. Starting therapy. All of this can be daunting and overwhelming. But you can be reassured that, together with a few tips, support, and commitment, it's possible to start on the right track. First things first, be sure to fill your XARELTO® prescription if you haven’t yet.

What is XARELTO®?

XARELTO® belongs to a group of medicines called direct oral anticoagulants, or DOACs for short. Like other DOACs, XARELTO® has no known dietary restrictions, no requirements for frequent blood tests, and few drug interactions.

How does XARELTO® work with aspirin?

Both XARELTO® and aspirin help prevent serious blood clots from forming and growing—but they work in different ways:

  • XARELTO® slows your body's ability to clot by selectively blocking one of the clotting factors found in your blood—an enzyme called Factor Xa ("10a").
  • Aspirin is an antiplatelet blood thinner that works by helping to keep platelets (which are pieces of blood cells) from sticking together and forming blood clots.

XARELTO® for people with CAD

XARELTO®, in combination with low-dose aspirin,* is the only drug in its class† indicated to help reduce the risk of heart attack, stroke, and cardiovascular death in adults with CAD.

*Low-dose aspirin = 75 mg-100mg once dialy.

†Direct oral anticoagulant (DOAC).

Almost 96% did not have
a cardiovascular
Almost 96% did not have a cardiovascular event

In a clinical trial,

almost 96% of the people did not have a heart attack or stroke, or die from a cardiovascular event.

The rate of the first event like a stroke, heart attack, or cardiovascular death was 4.2% for people taking XARELTO® plus low-dose aspirin vs 5.6% for low-dose aspirin alone. Patients were followed for an average of 23 months.

Remember, all blood thinners come with a risk of bleeding. Around 3% of people taking XARELTO® 2.5 mg twice daily in combination with low-dose aspirin experienced a major bleeding event, such as bleeding into the brain, compared to around 2% of people taking low-dose aspirin alone.